| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.059 | 0.3 |